Free study report

4,884 patients. One question: did Aptogenix make a difference?

An independent retrospective analysis by OvationLab compared people who completed the Vibility program with and without Aptogenix supplements. The Aptogenix group showed greater improvement on every measure studied.

For integrative & functional practitioners · Free PDF · Instant access

The Aptogenix Effect: retrospective study report cover
4,884program completers analyzed
58.8%used at least one Aptogenix product
100%of measured subdomains favored the Aptogenix group
p ≤ 0.02on every between-group comparison
Independent research

Designed, run and interpreted outside the company

OvationLab, led by Chris D’Adamo, PhD of the University of Maryland School of Medicine, analyzed existing records from the Vibility program. Aptogenix did not run the analysis.

“Our analysis of nearly 5,000 patients who had completed a Vibility program revealed a dramatic 52.7% improvement in their mean MSQ scores along with statistically significant and clinically meaningful improvements in PROMIS-29 mental and physical health scores (p<0.0001 for all results). These findings reflect impressive and multidimensional symptom improvements among patients who completed Vibility programs.”
Chris D’Adamo, PhDOvationLab · University of Maryland School of Medicine
The results

Both groups improved. The Aptogenix group improved more.

Average improvement from start to finish of the program on two widely used questionnaires: the Medical Symptoms Questionnaire (MSQ) and the PROMIS-29 physical and mental health scores.

Aptogenix usersNon-users

Symptom burden

MSQ total, points improved
38.7
34.5
Between-group p = 0.0002

Physical health

PROMIS-29 physical, points improved
1.91
1.43
Between-group p = 0.02

Mental health

PROMIS-29 mental, points improved
4.92
4.26
Between-group p = 0.0003

Observational results among people who chose to use Aptogenix products. They show an association, not proof that the products caused the difference.

The full report breaks results down by every subdomain, with methods and group details. See all results
How the study worked

Real-world patients, real-world practice

01

Existing program data

The analysis looked back at records from 4,884 people who completed the Vibility lifestyle program with their practitioners.

02

Two groups compared

Participants who used an Aptogenix product were compared with those who didn’t, on the same program and questionnaires.

03

Independent analysis

OvationLab ran the statistics and interpreted the findings, independent of Aptogenix.

Also in the report

More than a headline number

Results by subdomain

Every MSQ and PROMIS-29 area measured, side by side for both groups.

Methods

How participants were grouped and how the comparisons were run.

The study population

Who completed the program and how many used Aptogenix products.

What comes next

The upcoming multi-site prospective study that builds on these findings with lab biomarkers.

Free download

Get your free copy of the study

  • Full results for Aptogenix users vs. non-users
  • Every MSQ and PROMIS-29 subdomain
  • Methods and study population
  • What the next study will measure

Get instant access

Enter your details and we’ll send the report straight to your inbox.

Loading form…

The Aptogenix product line
Not an FPC practice?

Order Aptogenix on Fullscript

The same formulas used in the study are available through Fullscript. Add them to your dispensary and recommend them to patients today.

  1. 1Sign in to your Fullscript dispensary
  2. 2Search “Aptogenix” to see the full line
  3. 3Add products to a protocol and send it to patients

Retrospective analysis of Vibility program completers conducted by OvationLab. Results are observational and do not establish causation.